Finder may earn compensation from partners, but editorial opinions are our own. Advertiser Disclosure

How to buy InVivo Therapeutics stock | $0.6371

Learn how to easily invest in InVivo Therapeutics stock.

InVivo Therapeutics Holdings Corp is a biotechnology business based in the US. InVivo Therapeutics shares (NVIV) are listed on the NASDAQ and all prices are listed in US Dollars. InVivo Therapeutics employs 6 staff and has a market cap (total outstanding shares value) of 0.00.

How to buy shares in InVivo Therapeutics

  1. Compare share trading platforms.Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – NVIV – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.

InVivo Therapeutics stock price (NASDAQ: NVIV)

Use our graph to track the performance of NVIV stocks over time.

InVivo Therapeutics shares at a glance

Information last updated 2021-10-17.
Latest market close$0.64
52-week range$0.50 - $2.00
50-day moving average $0.65
200-day moving average $0.71
Wall St. target price$37.50
PE ratio N/A
Dividend yield N/A (0%)
Earnings per share (TTM) $-0.42

Buy InVivo Therapeutics shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
Name Product Asset types Option trade fee Annual fee Signup bonus
Robinhood
Robinhood
Stocks, Options, ETFs, Cryptocurrency
$0
0%
Free stock (chosen randomly with a value anywhere between $2.50 and $200)
Sign up using the "go to site" link
Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.
J.P. Morgan Self-Directed Investing
Stocks, Bonds, Options, Mutual funds, ETFs
$0 + $0.65/contract
0%
N/A
INVESTMENT AND INSURANCE PRODUCTS ARE: NOT A DEPOSIT • NOT FDIC INSURED • NO BANK GUARANTEE • MAY LOSE VALUE
Vanguard Personal Advisor
Stocks, Options, Mutual funds, ETFs
N/A
$20 per year
N/A
Financial advice powered by relationships, not commissions.
TradeStation
Stocks, Bonds, Options, Mutual funds, ETFs, Cryptocurrency
$0 + $0.50/contract
$0 per month
$50
Deposit qualifying assets of $5,000+
A platform built for all kinds of traders and all styles of trading
Sofi Invest
Stocks, ETFs, Cryptocurrency
N/A
0%
Get one free stock worth up to $1,000
Open an account
A free way to invest in stocks, ETFs and crypto.
Moomoo
Stocks
$0
$0 per year
Get a free stock valued up to $350
Open your Futu brokerage account via Moomoo
Trade stocks on the US, Hong Kong, Shanghai and Shenzhen markets.
loading

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy InVivo Therapeutics stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

InVivo Therapeutics price performance over time

Historical closes compared with the close of $0.6371 from 2021-10-20

1 week (2021-10-14) -0.45%
1 month (2021-09-21) 6.18%
3 months (2021-07-21) -6.31%
6 months (2021-04-21) -16.17%
1 year (2020-10-21) -44.11%
2 years (2019-10-21) 30.02%
3 years (2018-10-19) 2.3996
5 years (2016-10-21) 4.95

InVivo Therapeutics financials

Gross profit TTM $0
Return on assets TTM -29.2%
Return on equity TTM -54.01%
Profit margin 0%
Book value $0.68
Market capitalisation $21.9 million

TTM: trailing 12 months

Shorting InVivo Therapeutics shares

There are currently 3.1 million InVivo Therapeutics shares held short by investors – that's known as InVivo Therapeutics's "short interest". This figure is 18.7% up from 2.6 million last month.

There are a few different ways that this level of interest in shorting InVivo Therapeutics shares can be evaluated.

InVivo Therapeutics's "short interest ratio" (SIR)

InVivo Therapeutics's "short interest ratio" (SIR) is the quantity of InVivo Therapeutics shares currently shorted divided by the average quantity of InVivo Therapeutics shares traded daily (recently around 788071.13402062). InVivo Therapeutics's SIR currently stands at 3.88. In other words for every 100,000 InVivo Therapeutics shares traded daily on the market, roughly 3880 shares are currently held short.

However InVivo Therapeutics's short interest can also be evaluated against the total number of InVivo Therapeutics shares, or, against the total number of tradable InVivo Therapeutics shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case InVivo Therapeutics's short interest could be expressed as 0.09% of the outstanding shares (for every 100,000 InVivo Therapeutics shares in existence, roughly 90 shares are currently held short) or 0.0893% of the tradable shares (for every 100,000 tradable InVivo Therapeutics shares, roughly 89 shares are currently held short).

Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against InVivo Therapeutics.

Find out more about how you can short InVivo Therapeutics stock.

InVivo Therapeutics share dividends

We're not expecting InVivo Therapeutics to pay a dividend over the next 12 months.

Have InVivo Therapeutics's shares ever split?

InVivo Therapeutics's shares were split on a 1:30 basis on 11 February 2020. So if you had owned 30 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your InVivo Therapeutics shares – just the quantity. However, indirectly, the new 2900% higher share price could have impacted the market appetite for InVivo Therapeutics shares which in turn could have impacted InVivo Therapeutics's share price.

InVivo Therapeutics share price volatility

Over the last 12 months, InVivo Therapeutics's shares have ranged in value from as little as $0.5 up to $2. A popular way to gauge a stock's volatility is its "beta".

NVIV.US volatility(beta: 1.27)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while InVivo Therapeutics's is 1.2672. This would suggest that InVivo Therapeutics's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).

InVivo Therapeutics overview

InVivo Therapeutics Holdings Corp. , a research and clinical-stage biomaterials and biotechnology company, engages in developing and commercializing biopolymer scaffolding devices for the treatment of spinal cord injuries (SCI). The company is developing a Neuro-Spinal Scaffold implant, which is an investigational bioresorbable polymer scaffold that is designed for implantation at the site of injury within a spinal cord to treat acute SCI. InVivo Therapeutics Holdings Corp. was incorporated in 2003 and is headquartered in Cambridge, Massachusetts. .

Frequently asked questions

What percentage of InVivo Therapeutics is owned by insiders or institutions?
Currently 2.169% of InVivo Therapeutics shares are held by insiders and 13.213% by institutions.
How many people work for InVivo Therapeutics?
Latest data suggests 6 work at InVivo Therapeutics.
When does the fiscal year end for InVivo Therapeutics?
InVivo Therapeutics's fiscal year ends in December.
Where is InVivo Therapeutics based?
InVivo Therapeutics's address is: One Kendall Square, Cambridge, MA, United States, 02139
What is InVivo Therapeutics's ISIN number?
InVivo Therapeutics's international securities identification number is: US46186M5067
What is InVivo Therapeutics's CUSIP number?
InVivo Therapeutics's Committee on Uniform Securities Identification Procedures number is: 46186M100

More guides on Finder

Ask an Expert

You are about to post a question on finder.com:

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • finder.com is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked

Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and finder.com Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site